After two decades in the making, scientists have cracked the code on a drug that can repair DNA, setting the scene for a new ...

Björn Pasternak, M.D., Ph.D. A new class of type 2 diabetes drug appears to reduce the risk of heart failure, death and major cardiovascular events, Scandinavian researchers have found. The results ...

A heart attack does more than block blood flow. Inside your body, it unleashes chaos. Heart cells flood with harmful oxygen ...

Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of ...

Experts released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM). The guideline reiterates the importance of collaborative ...

TY1 enhances the action of TREX1, a gene that helps immune cells clear damaged DNA, helping to minimize scar tissue post heart attacks.

Updates to national guidelines for the management of hypertrophic cardiomyopathy (HCM) endorse cardiac myosin inhibitor use in certain cases, greenlight more intensive physical activity, and expand ...

Wegovy is part of a class of drugs called GLP-1 Receptor Agonists. Taking a weight loss drug may also help reduce the risk of heart attack, stroke and cardiac death, data shows. Wegovy, a drug ...

Aficamten shows cardiac benefits over blood pressure drug metoprolol Analysts see potential for aficamten to replace beta-blocker drugs for treating HCM Cytokinetics plans to submit data to regulators ...